Show simple item record

dc.contributor.authorKeliher, Edmund J.
dc.contributor.authorDougan, Michael
dc.contributor.authorCavallari, Marco
dc.contributor.authorWojtkiewicz, Gregory R.
dc.contributor.authorJacobsen, Johanne T.
dc.contributor.authorEdens, Jerre G.
dc.contributor.authorTas, Jeroen M. J.
dc.contributor.authorVictora, Gabriel
dc.contributor.authorWeissleder, Ralph
dc.contributor.authorRashidian, Mohammad
dc.contributor.authorJuras, Patrick K.
dc.contributor.authorPloegh, Hidde
dc.date.accessioned2017-04-25T16:32:19Z
dc.date.available2017-04-25T16:32:19Z
dc.date.issued2015-06
dc.date.submitted2015-03
dc.identifier.issn2374-7943
dc.identifier.issn2374-7951
dc.identifier.urihttp://hdl.handle.net/1721.1/108397
dc.description.abstractWe generated [superscript 18]F-labeled antibody fragments for positron emission tomography (PET) imaging using a sortase-mediated reaction to install a trans-cyclooctene-functionalized short peptide onto proteins of interest, followed by reaction with a tetrazine-labeled-[superscript 18]F-2-deoxyfluoroglucose (FDG). The method is rapid, robust, and site-specific (radiochemical yields > 25%, not decay corrected). The availability of [superscript 18]F-2-deoxyfluoroglucose avoids the need for more complicated chemistries used to generate carbon–fluorine bonds. We demonstrate the utility of the method by detecting heterotopic pancreatic tumors in mice by PET, using anti-Class II MHC single domain antibodies. We correlate macroscopic PET images with microscopic two-photon visualization of the tumor. Our approach provides easy access to [superscript 18]F-labeled antibodies and their fragments at a level of molecular specificity that complements conventional [superscript 18]F-FDG imaging.en_US
dc.description.sponsorshipNational Cancer Institute (U.S.)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (R01-AI087879-06)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Pioneer Award DP1-GM106409-03)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (R01-GM100518-04)en_US
dc.description.sponsorshipLustgarten Foundationen_US
dc.language.isoen_US
dc.publisherAmerican Chemical Society (ACS)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1021/acscentsci.5b00121en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceACSen_US
dc.titleUse of [superscript 18]F‑2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Canceren_US
dc.typeArticleen_US
dc.identifier.citationRashidian, Mohammad et al. “Use of 18 F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer.” ACS Central Science 1.3 (2015): 142–147. © 2015 American Chemical Societyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentWhitehead Institute for Biomedical Researchen_US
dc.contributor.mitauthorRashidian, Mohammad
dc.contributor.mitauthorJuras, Patrick K.
dc.contributor.mitauthorPloegh, Hidde
dc.relation.journalACS Central Scienceen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsRashidian, Mohammad; Keliher, Edmund J.; Dougan, Michael; Juras, Patrick K.; Cavallari, Marco; Wojtkiewicz, Gregory R.; Jacobsen, Johanne T.; Edens, Jerre G.; Tas, Jeroen M. J.; Victora, Gabriel; Weissleder, Ralph; Ploegh, Hiddeen_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-1090-6071
mit.licensePUBLISHER_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record